13D Filing: Sagard Capital Partners, L.P. and Jaguar Health Inc. (JAGX)

Page 21 of 25

Page 21 of 25 – SEC Filing

 

(vi)

None

(vii)

None

 

 

(i)

Isabelle Marcoux

(ii)

Director

(iii)

Canada

(iv)

Chair of the Board, Transcontinental Inc.

(v)

1 Place Ville-Marie, Suite 3240, Montréal (Québec), Canada H3B 0G1

(vi)

None

(vii)

None

 

 

(i)

R. Jeffrey Orr

(ii)

Director

(iii)

Canada

(iv)

President and Chief Executive Officer, Power Financial Corporation

(v)

751 Victoria Square, Montréal (Québec), Canada H2Y 2J3

(vi)

None

(vii)

None

 

 

(i)

Michel Plessis-Bélair

(ii)

Executive Officer

(iii)

Canada

(iv)

Vice-Chairman, Power Corporation of Canada

(v)

751 Victoria Square, Montréal (Québec), Canada H2Y 2J3

(vi)

None

(vii)

None

 

 

(i)

J. David A. Jackson

(ii)

Director

(iii)

Canada

(iv)

Partner Emeritus and Senior Counsel, Blake, Cassels & Graydon LLP

(v)

199 Bay Street, Suite 4000, Commerce Court W., Toronto (Ontario), Canada M5L 1A9

(vi)

None

(vii)

None

 

 

(i)

T. Timothy Ryan, Jr.

(ii)

Director

(iii)

United States of America

(iv)

Company Director

(v)

10295 Collins Avenue, Unit 404, Bal Harbour, FL, USA 33154

(vi)

None

(vii)

None

 

 

(i)

Emoke J.E. Szathmáry

(ii)

Director

(iii)

Canada

(iv)

President Emeritus, University of Manitoba

(v)

70 Dysart Road, Room 112, Winnipeg (Manitoba), Canada R3T 2M6

(vi)

None

(vii)

None

 

 

(i)

Gregory D. Tretiak

(ii)

Executive Officer

 

20


Follow Jaguar Health Inc. (NASDAQ:JAGX)

Page 21 of 25